Used in pharmaceutical research as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system agents. Its structure supports the development of compounds targeting neurological disorders such as depression, anxiety, and obsessive-compulsive disorder. The compound's indoline backbone and amine functionality enhance binding affinity to serotonin receptors, making it valuable in medicinal chemistry for optimizing drug candidates. Also explored in the design of receptor antagonists and enzyme inhibitors due to its favorable pharmacokinetic properties and ability to cross the blood-brain barrier.